fda drug shortages semaglutide injection status resolved 2025 As of February 21, 2025, the updated its shortage list, marking the shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The GLP-1 drug shortage is

And the solution whether it involves medication, abstinence, or both was never going to be just about turning down the cravings

Semaglutide is especially beneficial for patients with non-alcoholic fatty liver disease (nafld) or those who struggle with weight management alongside metabolic challenges

Helps control hunger, cravings, and portion sizes

Framing non-approved medications as automatically unsafe ignores that all currently approved medications were once non-approved medications working through the same process

Stabilizing therapies for acute mitral regurgitation include afterload reduction with vasodilators, diuresis as needed to reduce pulmonary edema, and mechanical circulatory support including intra-aortic balloon pumps

This in turn has led to shortages of the drug